Q4 2024 Management View CEO Randall Lipps highlighted that Omnicell exceeded bookings guidance for 2024, driven by strong connected devices demand. He emphasized the traction of the XT Amplify program ...

Madison Square Garden Entertainment Corp. (NYSE:MSGE) Q2 2025 Management View Interim CFO Lee Weinberg highlighted strong demand for in-person experiences, with total revenues of $407 million and ...

Capri Holdings, owner of the Versace, Jimmy Choo and Michael Kors brands, has reported total revenue of $1.26bn in the third ...

The Greenwich, Conn.-based less-than-truckload carrier posted net income of $76 million, compared with $58 million during the ...

Ford Motor Co. in Dearborn reported fourth-quarter 2024 revenue of $48.2 billion and a total of $185 billion for 2024, the ...

Medpace demonstrates strong financial performance and growth in the CRO market, despite facing challenges in the short term. Read why MEDP stock is a Strong Buy.

Commercial stage pharmaceutical firm Shield Therapeutics, which has a base in Gateshead, has significantly improved its revenues and strengthened its balance sheet.

Julius Berger has reported a pre-tax profit of N29.5 billion for the full year ending December 31, 2024, as outlined ...